Athanor Capital, LP Deciphera Pharmaceuticals, Inc. Transaction History

Athanor Capital, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$40.39 - $56.73 $254,053 - $356,831	-6,290 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$51.77 - $66.18 $325,633 - $416,272	6,290 New	6,290 $359,000
Q1 2020 May 14, 2020	SELL	$33.63 - $69.4 $369,223 - $761,942	-10,979 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$31.7 - $69.93 $348,034 - $767,761	10,979 New	10,979 $683,000

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Athanor Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Athanor Capital, LP with notifications on news.